急性重型颅脑损伤中纳美芬与神经节苷脂联合治疗的临床疗效观察  

Clinical Efficacy of Nalmefene and Ganglioside Combined Treatment of Acute Severe Craniocerebral Injury

作　　者：韩东[1] 宋伟[1] 夏国庆[1] 王东晓[1] 王卿峰[1] 祝启海 

机构地区：[1]河南省焦作市第二人民医院神经外科,454150

出　　处：《中国继续医学教育》2016年第8期165-165,共1页China Continuing Medical Education

摘　　要：目的分析急性重型颅脑损伤中纳美芬与神经节苷脂联合治疗的临床效果。方法收集我院急性重型颅脑损伤患者,随机分为观察组和对照组,各52例。观察组采用传统的治疗方案,对照组在传统治疗方案上行盐酸纳美芬与神经节苷脂联合治疗,对比两组的治疗效果。结果对比两组的治疗临床效果,差异具有统计学意义(P<0.05)。结论纳美芬联合神经节苷脂在治疗急性重型颅脑损伤效果良好。Objective To analyze the acute severe craniocerebral injury in nalmefene and ganglioside combined treatment. Methods Made a collection of acute severe brain injury in our hospital, and randomly divided into observation group and control group（52 cases in each group）. Observation group was treated with traditional treatment, the control group was treated with traditional treatment upstream of nalmefene hydrochloride and ganglioside combination therapy. Compared the treatment effect of the two groups. Results Made a comparison of clinical effects of two groups, the difference was statistically significant（P0.05）. Conclusion Nalmefene combined with ganglioside in the treatment of acute severe craniocerebral injury has good results.

关 键 词：急性重型颅脑损伤 神经节苷脂 纳美芬 

分 类 号：R651.15[医药卫生—外科学]